Table 5.
2016 | 2017 | 2018 | 2019 | 2020 | 2025 | |
---|---|---|---|---|---|---|
Base | ||||||
Treated | 36,600 | 23,000 | 19,000 | 12,900 | 12,500 | 12,500 |
Newly diagnosed | 18,800 | 30,000 | 30,000 | 30,000 | 30,000 | 30,000 |
Number needed to screen (gen. pop.) | 3,889,000 | 9,000,000 | 9,585,000 | 10,246,000 | 10,991,000 | 16,763,000 |
Number needed to screen (high risk. pop.) | 778,000 | 1,800,000 | 1,917,000 | 2,049,000 | 2,198,000 | 3,353,000 |
NSP | ||||||
Treated | 36,600 | 23,000 | 19,000 | 50,000 | 50,000 | 32,000 |
Newly diagnosed | 18,800 | 30,000 | 30,000 | 40,000 | 40,000 | 40,000 |
Number needed to screen (gen. pop.) | 3,889,000 | 9,000,000 | 9,598,000 | 13,975,000 | 15,469,000 | 30,997,000 |
Number needed to screen (high risk. pop.) | 780,000 | 1,800,000 | 1,920,000 | 2,795,000 | 3,094,000 | 6,199,000 |
NSP, national strategy plan.